{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:43:36Z","timestamp":1789469016289,"version":"build-2803163510"},"reference-count":48,"publisher":"Japanese Society of Allergology","issue":"2","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T00:00:00Z","timestamp":1430265600000},"content-version":"vor","delay-in-days":3040,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2007]]},"DOI":"10.2332\/allergolint.r-07-144","type":"journal-article","created":{"date-parts":[[2007,6,18]],"date-time":"2007-06-18T06:18:15Z","timestamp":1182147495000},"page":"105-111","source":"Crossref","is-referenced-by-count":24,"title":["Therapeutic Strategies for Systemic Necrotizing Vasculitides"],"prefix":"10.2332","volume":"56","author":[{"given":"Lo\u00efc","family":"Guillevin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Pagnoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1154","reference":[{"key":"10.2332\/allergolint.R-07-144_bb0005","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/art.1780330805","article-title":"The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa","volume":"33","author":"Lightfoot","year":"1990","journal-title":"Arthritis Rheum."},{"key":"10.2332\/allergolint.R-07-144_bb0010","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/art.1780330806","article-title":"The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis)","volume":"33","author":"Masi","year":"1990","journal-title":"Arthritis Rheum."},{"key":"10.2332\/allergolint.R-07-144_bb0015","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","article-title":"The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis","volume":"33","author":"Leavitt","year":"1990","journal-title":"Arthritis Rheum."},{"key":"10.2332\/allergolint.R-07-144_bb0020","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides. Proposal of an international consensus conference","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.2332\/allergolint.R-07-144_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ki.1994.239","article-title":"Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential","volume":"46","author":"Kallenberg","year":"1994","journal-title":"Kidney Int."},{"key":"10.2332\/allergolint.R-07-144_bb0030","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/1529-0131(199904)42:3<421::AID-ANR5>3.0.CO;2-6","article-title":"Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients","volume":"42","author":"Guillevin","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.2332\/allergolint.R-07-144_bb0035","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1002\/art.21250","article-title":"Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome","volume":"52","author":"Sinico","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.2332\/allergolint.R-07-144_bb0040","doi-asserted-by":"crossref","first-page":"632","DOI":"10.7326\/0003-4819-143-9-200511010-00006","article-title":"Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome","volume":"143","author":"Sable-Fourtassou","year":"2005","journal-title":"Ann. Intern. Med."},{"key":"10.2332\/allergolint.R-07-144_bb0045","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/01.md.0000180792.80212.5e","article-title":"Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients","volume":"84","author":"Guillevin","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"10.2332\/allergolint.R-07-144_bb0050","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00005792-199901000-00003","article-title":"Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients","volume":"78","author":"Guillevin","year":"1999","journal-title":"Medicine (Baltimore)"},{"key":"10.2332\/allergolint.R-07-144_bb0055","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","article-title":"Wegener granulomatosis: an analysis of 158 patients","volume":"116","author":"Hoffman","year":"1992","journal-title":"Ann. Intern. Med."},{"key":"10.2332\/allergolint.R-07-144_bb0060","first-page":"121","article-title":"HIV-related vasculitis: clinical presentation and therapeutic approach on six patients [letter]","volume":"11","author":"Gisselbrecht","year":"1997","journal-title":"Aids"},{"key":"10.2332\/allergolint.R-07-144_bb0065","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/art.1780341221","article-title":"Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia","volume":"34","author":"Ferri","year":"1991","journal-title":"Arthritis Rheum."},{"key":"10.2332\/allergolint.R-07-144_bb0070","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/art.20958","article-title":"PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis","volume":"52","author":"Cacoub","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.2332\/allergolint.R-07-144_bb0075","first-page":"71","article-title":"Hepatitis C virus-related cryoglobulinemia and glomerulonephritis: pathogenesis and therapeutic strategies","volume":"20","author":"Garini","year":"2005","journal-title":"Ann. Ital. Med. Int."},{"key":"10.2332\/allergolint.R-07-144_bb0080","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1182\/blood-2002-09-2856","article-title":"Efficacy and safety of rituximab in type II mixed cryoglobulinemia","volume":"101","author":"Zaja","year":"2003","journal-title":"Blood"},{"key":"10.2332\/allergolint.R-07-144_bb0085","first-page":"398","article-title":"Human immunodeficiency virus-related vasculitis. Clinical presentation of and therapeutic approach to eight cases","volume":"149","author":"Gisselbrecht","year":"1998","journal-title":"Ann. Med. Interne"},{"key":"10.2332\/allergolint.R-07-144_bb0090","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00005792-199601000-00003","article-title":"Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients","volume":"75","author":"Guillevin","year":"1996","journal-title":"Medicine (Baltimore)"},{"key":"10.2332\/allergolint.R-07-144_bb0095","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/1529-0131(200103)44:3<666::AID-ANR116>3.0.CO;2-A","article-title":"Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients","volume":"44","author":"Gayraud","year":"2001","journal-title":"French Vasculitis Study Group. Arthritis Rheum."},{"key":"10.2332\/allergolint.R-07-144_bb0100","first-page":"671","article-title":"Birmingham Vas- culitis Activity Score (BVAS) in systemic necrotizing vasculitis","volume":"87","author":"Luqmani","year":"1994","journal-title":"Qjm"},{"key":"10.2332\/allergolint.R-07-144_bb0105","series-title":"Treatment of Churg- Srauss syndrome without poor prognostic factors. A prospective randomized study in seventy two patients","author":"Ribi","year":"2007"},{"key":"10.2332\/allergolint.R-07-144_bb0110","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0002-9343(67)90144-1","article-title":"Long term follow-up study of polyar- teritis nodosa","volume":"43","author":"Frohnert","year":"1967","journal-title":"Am. J. Med."},{"key":"10.2332\/allergolint.R-07-144_bb0115","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/art.10922","article-title":"Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-fve patients","volume":"49","author":"Guillevin","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.2332\/allergolint.R-07-144_bb0120","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","article-title":"A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies","volume":"349","author":"Jayne","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.2332\/allergolint.R-07-144_bb0125","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/art.21142","article-title":"Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis","volume":"52","author":"De Groot","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.2332\/allergolint.R-07-144_bb0130","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/art.20240","article-title":"Mycophenolate mofetil for remission maintenance in the treatment of Wegener's granulomatosis","volume":"51","author":"Langford","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.2332\/allergolint.R-07-144_bb0135","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/art.1780401213","article-title":"A prospective, multi-center, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis","volume":"40","author":"Guillevin","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.2332\/allergolint.R-07-144_bb0140","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/qjmed\/90.6.401","article-title":"Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis","volume":"90","author":"Adu","year":"1997","journal-title":"Qjm"},{"key":"10.2332\/allergolint.R-07-144_bb0145","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1681\/ASN.V7133","article-title":"Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis","volume":"7","author":"Nachman","year":"1996","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.2332\/allergolint.R-07-144_bb0150","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/ki.1991.272","article-title":"Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies","volume":"40","author":"Pusey","year":"1991","journal-title":"Kidney Int."},{"key":"10.2332\/allergolint.R-07-144_bb0155","series-title":"Randomised trial of plasma exchange versus methyl prednisolone for severe renal vasculitis","author":"Jayne","year":"2006"},{"key":"10.2332\/allergolint.R-07-144_bb0160","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/qjmed\/93.7.433","article-title":"Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity","volume":"93","author":"Jayne","year":"2000","journal-title":"Qjm"},{"key":"10.2332\/allergolint.R-07-144_bb0165","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1093\/rheumatology\/35.11.1150","article-title":"Intravenous immunoglobulins as sole therapy for systemic vasculitis","volume":"35","author":"Jayne","year":"1996","journal-title":"Br. J. Rheumatol."},{"key":"10.2332\/allergolint.R-07-144_bb0170","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1136\/ard.2002.003996","article-title":"Intravenous immunoglobulins in peripheral neuropathy associated with vasculitis","volume":"62","author":"Levy","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.2332\/allergolint.R-07-144_bb0175","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2249.1995.tb02268.x","article-title":"Treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis with high-dose intravenous immunoglobulin","volume":"101","author":"Richter","year":"1995","journal-title":"Clin. Exp. Immunol."},{"key":"10.2332\/allergolint.R-07-144_bb0180","article-title":"Groupe Frangais d' Etudes des Vascularites. Intravenous immunoglobulins for relapses of ANCA-associated systemic vasculitides: final analysis of a prospective, open and multicenter trial. American College of Rheumatology, San Diego, poster 1752","author":"Martinez","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.2332\/allergolint.R-07-144_bb0185","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1056\/NEJM199412153312402","article-title":"Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin","volume":"331","author":"Bjoro","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.2332\/allergolint.R-07-144_bb0190","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000056085","article-title":"Adverse effects of intravenous immunoglobulin therapy in 56 patients with autoimmune diseases","volume":"62","author":"Sherer","year":"2001","journal-title":"Pharmacology"},{"key":"10.2332\/allergolint.R-07-144_bb0195","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1006\/jaut.1993.1018","article-title":"ANCA antiidiotype antibodies and the treatment of systemic vasculitis with intravenous immunoglobulin","volume":"6","author":"Jayne","year":"1993","journal-title":"J. Autoimmun."},{"key":"10.2332\/allergolint.R-07-144_bb0200","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0755-4982(05)84104-1","article-title":"Pathogenie des vascularites systemiques primitives (I): Les vascularites ANCA positives","volume":"34","author":"Guilpain","year":"2005","journal-title":"Presse. Med."},{"key":"10.2332\/allergolint.R-07-144_bb0205","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/rheumatology\/41.10.1126","article-title":"Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients","volume":"41","author":"Bartolucci","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.2332\/allergolint.R-07-144_bb0210","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/01.ASN.0000114554.67106.28","article-title":"Prospective study of TNFalpha blockade with infliximab in antineutrophil cytoplasmic antibody-associated systemic vasculitis","volume":"15","author":"Booth","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.2332\/allergolint.R-07-144_bb0215","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa041884","article-title":"Etanercept plus standard therapy for Wegener's granulomatosis","volume":"352","author":"The Wegener's Granulomatosis Etanercept Trial (WGET) Research Group","year":"2005","journal-title":"N. Engl. J. Med"},{"key":"10.2332\/allergolint.R-07-144_bb0220","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1164\/rccm.200507-1144OC","article-title":"Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial","volume":"173","author":"Keogh","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.2332\/allergolint.R-07-144_bb0225","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1365-2796.2005.01494.x","article-title":"Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab","volume":"257","author":"Eriksson","year":"2005","journal-title":"J. Intern. Med."},{"key":"10.2332\/allergolint.R-07-144_bb0230","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/j.1523-1755.2004.00534.x","article-title":"Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients","volume":"65","author":"Schmitt","year":"2004","journal-title":"Kidney Int."},{"key":"10.2332\/allergolint.R-07-144_bb0235","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1365-2249.2001.01575.x","article-title":"Increased expression of CTLA-4 (CD152) by T and B lymphocytes in Wegener's granulomatosis","volume":"126","author":"Steiner","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"10.2332\/allergolint.R-07-144_bb0240","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jaut.2005.08.004","article-title":"BAFF is elevated in serum of patients with Wegener's granulomatosis","volume":"25","author":"Krumbholz","year":"2005","journal-title":"J. Autoimmun."}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1323893015308546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1323893015308546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,15]],"date-time":"2021-08-15T02:37:35Z","timestamp":1628995055000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1323893015308546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007]]}},"alternative-id":["S1323893015308546"],"URL":"https:\/\/doi.org\/10.2332\/allergolint.r-07-144","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2007]]}}}